Clinical trial
PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive…
NCT00107848 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00107848 |
|---|---|
| Title | PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome |
| Official title | A 1 Year Open Label, Flexible Dosage Extension Study to Assess the Safety and Continued Effectiveness of PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Narcolepsy, Sleep Apnea, Obstructive |
| Intervention type | Drug |
| Interventions | Modafinil |
| Enrollment | 280 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Apr 11, 2005 |
| Last update posted | May 9, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: